Canadian Urological Association Guideline: Muscle-invasive Bladder Cancer

原文：2019年发布于 Canadian Urological Association Journal 13卷第8期 230-238  浏览量：279次 原文链接

作者： Canadian Urological Association

归属分类：膀胱肿瘤临床实践指南

关键词： Muscle-invasive Bladder Cancer Guideline

文献简介

无

原文网址：https://pubmed.ncbi.nlm.nih.gov/30763236/

EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-an International Collaborative Multi-stakeholder Effort: Under the Auspices of the EAU and ESMO Guidelines Committees

SIU-ICUD Consultation on Bladder Cancer: Treatment of Muscle-invasive Bladder Cancer

热门文献

GSTM1 and GSTT1 polymorphisms are associated with increased bladder cancer risk: Evidence from updated meta-analysis

 Clin Invest Med 1299
Efficacy and toxicity in scheduled intravesical gemcitabine versus Bacille Calmette-Guerin for Ta and T1 bladder cancer: a systematic review and meta-analysis

 J Cancer Res Ther 39 卷第 6 期 906
吉西他滨较丝裂霉素治疗 TURBT 后非肌层浸润性膀胱癌的复发率低、毒副作用小 : 基于随机对照试验的荟萃分析

 PeerJ 60 卷第 5 期 869
Urinary human papilloma virus infection and bladder cancer risk: A systematic review and a prisma-compliant meta-analysis

 Int J Nurs Pract 13 卷第 4 期 808
Clinicopathological and Prognostic Value of Ki-67 Expression in Bladder Cancer: A Systematic Review and Meta-Analysis

 Bmc Urology 756
Comparison of the prognosis of primary and progressive muscle-invasive bladder cancer after radical cystectomy: A systematic review and meta-analysis

 Oncotarget 732
Meta-analysis of a 10-plex urine-based biomarker assay for the detection of bladder cancer

 Eur J Nutr 11 卷第 2 期 722
[Adjuvant radiotherapy after radical cystectomy for muscle-invasive bladder cancer]

 Front Endocrinol (Lausanne) 13 卷第 11 期 713
膀胱癌标本规范化处理和病理诊断共识

 中华病理学杂志 49卷第4期 692
Clinical Outcomes after Intravesical Bacillus Calmette–Guérin for the Highest-risk Non-muscle-invasive Bladder Cancer Newly Defined in the Japanese Urological Association Guidelines 2019

 International Journal of Urology 685

Canadian Urological Association Guideline: Muscle-invasive Bladder Cancer

原文：2019年发布于 Canadian Urological Association Journal 13卷第8期 230-238  浏览量：279次 原文链接

文献简介

上一篇

EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-an International Collaborative Multi-stakeholder Effort: Under the Auspices of the EAU and ESMO Guidelines Committees

下一篇

SIU-ICUD Consultation on Bladder Cancer: Treatment of Muscle-invasive Bladder Cancer

GSTM1 and GSTT1 polymorphisms are associated with increased bladder cancer risk: Evidence from updated meta-analysis

Efficacy and toxicity in scheduled intravesical gemcitabine versus Bacille Calmette-Guerin for Ta and T1 bladder cancer: a systematic review and meta-analysis

吉西他滨较丝裂霉素治疗 TURBT 后非肌层浸润性膀胱癌的复发率低、毒副作用小 : 基于随机对照试验的荟萃分析

Urinary human papilloma virus infection and bladder cancer risk: A systematic review and a prisma-compliant meta-analysis

Clinicopathological and Prognostic Value of Ki-67 Expression in Bladder Cancer: A Systematic Review and Meta-Analysis

Comparison of the prognosis of primary and progressive muscle-invasive bladder cancer after radical cystectomy: A systematic review and meta-analysis

Meta-analysis of a 10-plex urine-based biomarker assay for the detection of bladder cancer

[Adjuvant radiotherapy after radical cystectomy for muscle-invasive bladder cancer]

膀胱癌标本规范化处理和病理诊断共识

Clinical Outcomes after Intravesical Bacillus Calmette–Guérin for the Highest-risk Non-muscle-invasive Bladder Cancer Newly Defined in the Japanese Urological Association Guidelines 2019

Canadian Urological Association Guideline: Muscle-invasive Bladder Cancer

原文：2019年 发布于 Canadian Urological Association Journal 13卷 第8期 230-238  浏览量：279次 原文链接

文献简介

上一篇

下一篇

原文：2019年发布于 Canadian Urological Association Journal 13卷第8期 230-238  浏览量：279次 原文链接